279 related articles for article (PubMed ID: 28288370)
1. The role of GPCRs in neurodegenerative diseases: avenues for therapeutic intervention.
Huang Y; Todd N; Thathiah A
Curr Opin Pharmacol; 2017 Feb; 32():96-110. PubMed ID: 28288370
[TBL] [Abstract][Full Text] [Related]
2. G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits.
Azam S; Haque ME; Jakaria M; Jo SH; Kim IS; Choi DK
Cells; 2020 Feb; 9(2):. PubMed ID: 32102186
[TBL] [Abstract][Full Text] [Related]
3. G-protein coupled receptors as therapeutic targets for neurodegenerative and cerebrovascular diseases.
Guerram M; Zhang LY; Jiang ZZ
Neurochem Int; 2016 Dec; 101():1-14. PubMed ID: 27620813
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders.
Lütjens R; Rocher JP
Curr Opin Pharmacol; 2017 Feb; 32():91-95. PubMed ID: 28135635
[TBL] [Abstract][Full Text] [Related]
5. Targeting erythropoietin for chronic neurodegenerative diseases.
Chong ZZ; Shang YC; Mu Y; Cui S; Yao Q; Maiese K
Expert Opin Ther Targets; 2013 Jun; 17(6):707-20. PubMed ID: 23510463
[TBL] [Abstract][Full Text] [Related]
6. Class II G protein-coupled receptors and their ligands in neuronal function and protection.
Martin B; Lopez de Maturana R; Brenneman R; Walent T; Mattson MP; Maudsley S
Neuromolecular Med; 2005; 7(1-2):3-36. PubMed ID: 16052036
[TBL] [Abstract][Full Text] [Related]
7. Design of multivalent ligand targeting G-protein-coupled receptors.
Liu Z; Zhang J; Zhang A
Curr Pharm Des; 2009; 15(6):682-718. PubMed ID: 19199990
[TBL] [Abstract][Full Text] [Related]
8. Orphan G protein-coupled receptors: The role in CNS disorders.
Alavi MS; Shamsizadeh A; Azhdari-Zarmehri H; Roohbakhsh A
Biomed Pharmacother; 2018 Feb; 98():222-232. PubMed ID: 29268243
[TBL] [Abstract][Full Text] [Related]
9. Targeting the dopamine D3 receptor: an overview of drug design strategies.
Cortés A; Moreno E; Rodríguez-Ruiz M; Canela EI; Casadó V
Expert Opin Drug Discov; 2016 Jul; 11(7):641-64. PubMed ID: 27135354
[TBL] [Abstract][Full Text] [Related]
10. Targeting TRPs in neurodegenerative disorders.
Takada Y; Numata T; Mori Y
Curr Top Med Chem; 2013; 13(3):322-34. PubMed ID: 23432063
[TBL] [Abstract][Full Text] [Related]
11. Map kinase signaling as therapeutic target for neurodegeneration.
Ahmed T; Zulfiqar A; Arguelles S; Rasekhian M; Nabavi SF; Silva AS; Nabavi SM
Pharmacol Res; 2020 Oct; 160():105090. PubMed ID: 32707231
[TBL] [Abstract][Full Text] [Related]
12. G protein-coupled receptors as promising cancer targets.
Liu Y; An S; Ward R; Yang Y; Guo XX; Li W; Xu TR
Cancer Lett; 2016 Jul; 376(2):226-39. PubMed ID: 27000991
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic induction of autophagy to modulate neurodegenerative disease progression.
Hochfeld WE; Lee S; Rubinsztein DC
Acta Pharmacol Sin; 2013 May; 34(5):600-4. PubMed ID: 23377551
[TBL] [Abstract][Full Text] [Related]
14. Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging.
Duda P; Wiśniewski J; Wójtowicz T; Wójcicka O; Jaśkiewicz M; Drulis-Fajdasz D; Rakus D; McCubrey JA; Gizak A
Expert Opin Ther Targets; 2018 Oct; 22(10):833-848. PubMed ID: 30244615
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.
Lappano R; Maggiolini M
Drugs; 2017 Jun; 77(9):951-965. PubMed ID: 28401445
[TBL] [Abstract][Full Text] [Related]
16. High bioavailability curcumin: an anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation.
Ullah F; Liang A; Rangel A; Gyengesi E; Niedermayer G; Münch G
Arch Toxicol; 2017 Apr; 91(4):1623-1634. PubMed ID: 28204864
[TBL] [Abstract][Full Text] [Related]
17. Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets.
Tang XL; Wang Y; Li DL; Luo J; Liu MY
Acta Pharmacol Sin; 2012 Mar; 33(3):363-71. PubMed ID: 22367282
[TBL] [Abstract][Full Text] [Related]
18. Antiapoptotic drugs: a therapautic strategy for the prevention of neurodegenerative diseases.
Sureda FX; Junyent F; Verdaguer E; Auladell C; Pelegri C; Vilaplana J; Folch J; Canudas AM; Zarate CB; Pallès M; Camins A
Curr Pharm Des; 2011; 17(3):230-45. PubMed ID: 21348832
[TBL] [Abstract][Full Text] [Related]
19. Insulin and neurodegenerative disease: shared and specific mechanisms.
Craft S; Watson GS
Lancet Neurol; 2004 Mar; 3(3):169-78. PubMed ID: 14980532
[TBL] [Abstract][Full Text] [Related]
20. Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer's disease.
Franco R; Martínez-Pinilla E; Navarro G; Zamarbide M
Prog Neurobiol; 2017; 149-150():21-38. PubMed ID: 28189739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
